Samsung Biologics Inks Deal to Mass-Produce COVID-19 Treatment
Samsung Biologics announced on Thursday that it signed with Vir Biotechnology Inc. a manufacturing agreement worth approximately $362 million (438 ...
Tag: Vir Biotechnology
FREE NEWSLETTER
Trending posts
- South Korea to Unveil Prototype of First Developed Fighter Jet KF-X
142 total views, 2 views today
- LG, Luxoft Join Hands to Officially Launch Automotive Solution Alluto
153 total views, 1 views today
- Hanwha to Strengthen Future Space Industry Growth With ‘Space Hub’
134 total views, 3 views today
- Naver Affiliate LINE Games Secures 100 Bln Won from China Firm Tencent
412 total views, 11 views today
- SK hynix Begins Mass-Producing Premium 18GB LPDDR5 mobile DRAM
122 total views, 3 views today
- SK Partners with Plug Power to Expand Asia’s Green Hydrogen Economy
151 total views, 2 views today
- Spotify Pulls Out K-Pop Music Provided by Kakao M
126 total views, 2 views today
- KT Expands Quantum Cryptographic Communication and Information Tech
93 total views, 5 views today
- Korean Startup Real Water’s Unique Solution to Keep Microplastics at Bay
120 total views, 1 views today
- Kakao Entertainment and SK Broadband To Deliver Diverse Content Selection
113 total views, 2 views today
Copyright © 2020 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy|Contact : [email protected] |